Provided by Dow Jones By Justina Lee Healthcare stocks are trading higher in Hong Kong, led by Shanghai Fosun Pharmaceutical (Group) Co., after it announced a joint venture with German biotechnology company BioNTech SE to manufacture and sell coronavirus vaccines. Shares of Shanghai-based Fosun Pharma rose as much as 23% to 61.35 Hong Kong dollars Monday morning, nearing a record, after the company said on Sunday it will have a plant in China capable of producing up to a billion doses annually of BioNTech's Covid-19 vaccine. Fosun Pharma's shares were recently trading 17% higher at HK$58.50, bringing its year-to-date gains to 58%. Gains by the stock and other Hong Kong-listed healthcare shares helped the Hang Seng Healthcare Index rise 2.7%. The broader Hang Seng Index was down 0.4%.